Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Extracellular vesicles of human pathogenic fungi.

Bielska E, May RC.

Curr Opin Microbiol. 2019 Jul 4;52:90-99. doi: 10.1016/j.mib.2019.05.007. [Epub ahead of print] Review.

PMID:
31280026
2.

Zinc and Iron Homeostasis: Target-Based Drug Screening as New Route for Antifungal Drug Development.

Simm C, May RC.

Front Cell Infect Microbiol. 2019 May 29;9:181. doi: 10.3389/fcimb.2019.00181. eCollection 2019.

3.

15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infection.

Evans RJ, Pline K, Loynes CA, Needs S, Aldrovandi M, Tiefenbach J, Bielska E, Rubino RE, Nicol CJ, May RC, Krause HM, O'Donnell VB, Renshaw SA, Johnston SA.

PLoS Pathog. 2019 Mar 28;15(3):e1007597. doi: 10.1371/journal.ppat.1007597. eCollection 2019 Mar.

4.

Application of High-Field Asymmetric Waveform Ion Mobility Separation to LESA Mass Spectrometry of Bacteria.

Kocurek KI, May RC, Cooper HJ.

Anal Chem. 2019 Apr 2;91(7):4755-4761. doi: 10.1021/acs.analchem.9b00307. Epub 2019 Mar 14.

PMID:
30835113
5.

A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.

Probert M, Zhou X, Goodall M, Johnston SA, Bielska E, Ballou ER, May RC.

Infect Immun. 2019 Mar 25;87(4). pii: e00731-18. doi: 10.1128/IAI.00731-18. Print 2019 Apr.

6.

Metabolome-wide association study of anti-epileptic drug treatment during pregnancy.

Walker DI, Perry-Walker K, Finnell RH, Pennell KD, Tran V, May RC, McElrath TF, Meador KJ, Pennell PB, Jones DP.

Toxicol Appl Pharmacol. 2019 Jan 15;363:122-130. doi: 10.1016/j.taap.2018.12.001. Epub 2018 Dec 4.

PMID:
30521819
7.

Transcriptional Heterogeneity of Cryptococcus gattii VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways.

Farrer RA, Ford CB, Rhodes J, Delorey T, May RC, Fisher MC, Cloutman-Green E, Balloux F, Cuomo CA.

mSphere. 2018 Oct 24;3(5). pii: e00445-18. doi: 10.1128/mSphere.00445-18.

8.

In Fungal Intracellular Pathogenesis, Form Determines Fate.

May RC, Casadevall A.

MBio. 2018 Oct 23;9(5). pii: e02092-18. doi: 10.1128/mBio.02092-18.

9.

Gene flow contributes to diversification of the major fungal pathogen Candida albicans.

Ropars J, Maufrais C, Diogo D, Marcet-Houben M, Perin A, Sertour N, Mosca K, Permal E, Laval G, Bouchier C, Ma L, Schwartz K, Voelz K, May RC, Poulain J, Battail C, Wincker P, Borman AM, Chowdhary A, Fan S, Kim SH, Le Pape P, Romeo O, Shin JH, Gabaldon T, Sherlock G, Bougnoux ME, d'Enfert C.

Nat Commun. 2018 Jun 8;9(1):2253. doi: 10.1038/s41467-018-04787-4.

10.

The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis.

Dambuza IM, Drake T, Chapuis A, Zhou X, Correia J, Taylor-Smith L, LeGrave N, Rasmussen T, Fisher MC, Bicanic T, Harrison TS, Jaspars M, May RC, Brown GD, Yuecel R, MacCallum DM, Ballou ER.

PLoS Pathog. 2018 May 18;14(5):e1006978. doi: 10.1371/journal.ppat.1006978. eCollection 2018 May.

11.

Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy.

Meador KJ, Pennell PB, May RC, Gerard E, Kalayjian L, Velez-Ruiz N, Penovich P, Cavitt J, French J, Hwang S, Pack AM, Sam M, Moore E, Ippolito DM; MONEAD Investigator Group.

Epilepsy Behav. 2018 Jul;84:10-14. doi: 10.1016/j.yebeh.2018.04.009. Epub 2018 May 3.

12.

Pathogen-derived extracellular vesicles mediate virulence in the fatal human pathogen Cryptococcus gattii.

Bielska E, Sisquella MA, Aldeieg M, Birch C, O'Donoghue EJ, May RC.

Nat Commun. 2018 Apr 19;9(1):1556. doi: 10.1038/s41467-018-03991-6.

13.

Variability in innate host immune responses to cryptococcosis.

Garelnabi M, May RC.

Mem Inst Oswaldo Cruz. 2018;113(7):e180060. doi: 10.1590/0074-02760180060. Epub 2018 Apr 16. Review.

14.

Characterizing the Mechanisms of Nonopsonic Uptake of Cryptococci by Macrophages.

Lim J, Coates CJ, Seoane PI, Garelnabi M, Taylor-Smith LM, Monteith P, Macleod CL, Escaron CJ, Brown GD, Hall RA, May RC.

J Immunol. 2018 May 15;200(10):3539-3546. doi: 10.4049/jimmunol.1700790. Epub 2018 Apr 11.

15.

Quantifying donor-to-donor variation in macrophage responses to the human fungal pathogen Cryptococcus neoformans.

Garelnabi M, Taylor-Smith LM, Bielska E, Hall RA, Stones D, May RC.

PLoS One. 2018 Mar 29;13(3):e0194615. doi: 10.1371/journal.pone.0194615. eCollection 2018.

16.

Editorial overview: Host-microbe interactions: fungi.

Brown GD, May RC.

Curr Opin Microbiol. 2017 Dec;40:v-vii. doi: 10.1016/j.mib.2017.11.026. No abstract available.

PMID:
29248117
17.

IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Salmonella Typhimurium.

Zhang Y, Dominguez-Medina C, Cumley NJ, Heath JN, Essex SJ, Bobat S, Schager A, Goodall M, Kracker S, Buckley CD, May RC, Kingsley RA, MacLennan CA, López-Macías C, Cunningham AF, Toellner KM.

J Immunol. 2017 Dec 15;199(12):4103-4109. doi: 10.4049/jimmunol.1700952. Epub 2017 Nov 10.

18.

A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).

Frey SE, Lottenbach K, Graham I, Anderson E, Bajwa K, May RC, Mizel SB, Graff A, Belshe RB.

Vaccine. 2017 Dec 4;35(48 Pt B):6759-6765. doi: 10.1016/j.vaccine.2017.09.070. Epub 2017 Oct 14.

PMID:
29037578
19.

Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5.

Gilbert AS, Seoane PI, Sephton-Clark P, Bojarczuk A, Hotham R, Giurisato E, Sarhan AR, Hillen A, Velde GV, Gray NS, Alessi DR, Cunningham DL, Tournier C, Johnston SA, May RC.

Sci Adv. 2017 Aug 16;3(8):e1700898. doi: 10.1126/sciadv.1700898. eCollection 2017 Aug.

20.

Top-Down LESA Mass Spectrometry Protein Analysis of Gram-Positive and Gram-Negative Bacteria.

Kocurek KI, Stones L, Bunch J, May RC, Cooper HJ.

J Am Soc Mass Spectrom. 2017 Oct;28(10):2066-2077. doi: 10.1007/s13361-017-1718-8. Epub 2017 Jul 5.

21.

Species-specific antifungal activity of blue light.

Trzaska WJ, Wrigley HE, Thwaite JE, May RC.

Sci Rep. 2017 Jul 4;7(1):4605. doi: 10.1038/s41598-017-05000-0.

22.

The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.

Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR, Bicanic TA, Castañeda E, Chang YC, Chen J, Cogliati M, Dromer F, Ellis D, Filler SG, Fisher MC, Harrison TS, Holland SM, Kohno S, Kronstad JW, Lazera M, Levitz SM, Lionakis MS, May RC, Ngamskulrongroj P, Pappas PG, Perfect JR, Rickerts V, Sorrell TC, Walsh TJ, Williamson PR, Xu J, Zelazny AM, Casadevall A.

mSphere. 2017 Jan 11;2(1). pii: e00357-16. doi: 10.1128/mSphere.00357-16. eCollection 2017 Jan-Feb.

23.

A Single-Cell Roadmap of Lineage Bifurcation in Human ESC Models of Embryonic Brain Development.

Yao Z, Mich JK, Ku S, Menon V, Krostag AR, Martinez RA, Furchtgott L, Mulholland H, Bort S, Fuqua MA, Gregor BW, Hodge RD, Jayabalu A, May RC, Melton S, Nelson AM, Ngo NK, Shapovalova NV, Shehata SI, Smith MW, Tait LJ, Thompson CL, Thomsen ER, Ye C, Glass IA, Kaykas A, Yao S, Phillips JW, Grimley JS, Levi BP, Wang Y, Ramanathan S.

Cell Stem Cell. 2017 Jan 5;20(1):120-134. doi: 10.1016/j.stem.2016.09.011. Epub 2016 Oct 27.

24.

Microevolutionary traits and comparative population genomics of the emerging pathogenic fungus Cryptococcus gattii.

Farrer RA, Voelz K, Henk DA, Johnston SA, Fisher MC, May RC, Cuomo CA.

Philos Trans R Soc Lond B Biol Sci. 2016 Dec 5;371(1709). pii: 20160021. doi: 10.1098/rstb.2016.0021.

25.

Erratum for Voelz et al., Cytokine Signaling Regulates the Outcome of Intracellular Macrophage Parasitism by Cryptococcus neoformans.

Voelz K, Lammas DA, May RC.

Infect Immun. 2016 Nov 18;84(12):3656. Print 2016 Dec. No abstract available.

26.

Using Flow Cytometry to Analyze Cryptococcus Infection of Macrophages.

Evans RJ, Voelz K, Johnston SA, May RC.

Methods Mol Biol. 2017;1519:349-357.

27.

New weapons in the Cryptococcus infection toolkit.

Taylor-Smith LM, May RC.

Curr Opin Microbiol. 2016 Dec;34:67-74. doi: 10.1016/j.mib.2016.07.018. Epub 2016 Aug 11. Review.

PMID:
27522351
28.

Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages.

Samantaray S, Correia JN, Garelnabi M, Voelz K, May RC, Hall RA.

Int J Antimicrob Agents. 2016 Jul;48(1):69-77. doi: 10.1016/j.ijantimicag.2016.04.018. Epub 2016 May 26.

29.

Custom-Made Quorum Sensing for a Eukaryote.

May RC.

Dev Cell. 2016 Jun 6;37(5):391-2. doi: 10.1016/j.devcel.2016.05.014.

30.

Cryptococcus neoformans Intracellular Proliferation and Capsule Size Determines Early Macrophage Control of Infection.

Bojarczuk A, Miller KA, Hotham R, Lewis A, Ogryzko NV, Kamuyango AA, Frost H, Gibson RH, Stillman E, May RC, Renshaw SA, Johnston SA.

Sci Rep. 2016 Feb 18;6:21489. doi: 10.1038/srep21489.

32.

Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis.

Madu UL, Ogundeji AO, Mochochoko BM, Pohl CH, Albertyn J, Swart CW, Allwood JW, Southam AD, Dunn WB, May RC, Sebolai OM.

Front Microbiol. 2015 Dec 9;6:1351. doi: 10.3389/fmicb.2015.01351. eCollection 2015.

33.

Cryptococcus: from environmental saprophyte to global pathogen.

May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K.

Nat Rev Microbiol. 2016 Feb;14(2):106-17. doi: 10.1038/nrmicro.2015.6. Epub 2015 Dec 21. Review.

34.

What makes Cryptococcus gattii a pathogen?

Bielska E, May RC.

FEMS Yeast Res. 2016 Feb;16(1):fov106. doi: 10.1093/femsyr/fov106. Epub 2015 Nov 26. Review.

PMID:
26614308
35.

Phase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis.

Cross AS, Greenberg N, Billington M, Zhang L, DeFilippi C, May RC, Bajwa KK.

Vaccine. 2015 Nov 27;33(48):6719-26. doi: 10.1016/j.vaccine.2015.10.072. Epub 2015 Oct 26.

36.

Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii.

Farrer RA, Desjardins CA, Sakthikumar S, Gujja S, Saif S, Zeng Q, Chen Y, Voelz K, Heitman J, May RC, Fisher MC, Cuomo CA.

MBio. 2015 Sep 1;6(5):e00868-15. doi: 10.1128/mBio.00868-15.

37.

pH manipulation as a novel strategy for treating mucormycosis.

Trzaska WJ, Correia JN, Villegas MT, May RC, Voelz K.

Antimicrob Agents Chemother. 2015 Nov;59(11):6968-74. doi: 10.1128/AAC.01366-15. Epub 2015 Aug 31.

38.

Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa.

Beale MA, Sabiiti W, Robertson EJ, Fuentes-Cabrejo KM, O'Hanlon SJ, Jarvis JN, Loyse A, Meintjes G, Harrison TS, May RC, Fisher MC, Bicanic T.

PLoS Negl Trop Dis. 2015 Jun 25;9(6):e0003847. doi: 10.1371/journal.pntd.0003847. eCollection 2015.

39.

Genome engineering of isogenic human ES cells to model autism disorders.

Martinez RA, Stein JL, Krostag AR, Nelson AM, Marken JS, Menon V, May RC, Yao Z, Kaykas A, Geschwind DH, Grimley JS.

Nucleic Acids Res. 2015 May 26;43(10):e65. doi: 10.1093/nar/gkv164. Epub 2015 Mar 11.

40.

Cryptococcal phospholipase B1 is required for intracellular proliferation and control of titan cell morphology during macrophage infection.

Evans RJ, Li Z, Hughes WS, Djordjevic JT, Nielsen K, May RC.

Infect Immun. 2015 Apr;83(4):1296-304. doi: 10.1128/IAI.03104-14. Epub 2015 Jan 20.

41.

The fungal pathogen Cryptococcus neoformans manipulates macrophage phagosome maturation.

Smith LM, Dixon EF, May RC.

Cell Microbiol. 2015 May;17(5):702-13. doi: 10.1111/cmi.12394. Epub 2014 Dec 19.

PMID:
25394938
42.

Antifungal resistance: more research needed.

Barnes RA, Gow NA, Denning DW, May RC, Haynes K; British Society of Medical Mycology.

Lancet. 2014 Oct 18;384(9952):1427. doi: 10.1016/S0140-6736(14)61861-4. Epub 2014 Oct 17. No abstract available.

PMID:
25390325
43.

Fungal Pathogens: Survival and Replication within Macrophages.

Gilbert AS, Wheeler RT, May RC.

Cold Spring Harb Perspect Med. 2014 Nov 10;5(7):a019661. doi: 10.1101/cshperspect.a019661. Review.

44.

'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak.

Voelz K, Johnston SA, Smith LM, Hall RA, Idnurm A, May RC.

Nat Commun. 2014 Oct 17;5:5194. doi: 10.1038/ncomms6194.

45.

Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal.

Springer DJ, Billmyre RB, Filler EE, Voelz K, Pursall R, Mieczkowski PA, Larsen RA, Dietrich FS, May RC, Filler SG, Heitman J.

PLoS Pathog. 2014 Aug 21;10(8):e1004285. doi: 10.1371/journal.ppat.1004285. eCollection 2014 Aug.

46.

Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal.

Engelthaler DM, Hicks ND, Gillece JD, Roe CC, Schupp JM, Driebe EM, Gilgado F, Carriconde F, Trilles L, Firacative C, Ngamskulrungroj P, Castañeda E, Lazera Mdos S, Melhem MS, Pérez-Bercoff A, Huttley G, Sorrell TC, Voelz K, May RC, Fisher MC, Thompson GR 3rd, Lockhart SR, Keim P, Meyer W.

MBio. 2014 Jul 15;5(4):e01464-14. doi: 10.1128/mBio.01464-14.

47.

Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates.

Chen Q, May RC, Ibrahim JG, Chu H, Cole SR.

Stat Med. 2014 Nov 20;33(26):4560-76. doi: 10.1002/sim.6242. Epub 2014 Jun 20.

48.

Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis.

Sabiiti W, Robertson E, Beale MA, Johnston SA, Brouwer AE, Loyse A, Jarvis JN, Gilbert AS, Fisher MC, Harrison TS, May RC, Bicanic T.

J Clin Invest. 2014 May;124(5):2000-8. doi: 10.1172/JCI72950. Epub 2014 Apr 17.

49.

Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010.

Head MG, Fitchett JR, Atun R, May RC.

BMJ Open. 2014 Jan 9;4(1):e004129. doi: 10.1136/bmjopen-2013-004129.

50.

Transmission of Hypervirulence traits via sexual reproduction within and between lineages of the human fungal pathogen cryptococcus gattii.

Voelz K, Ma H, Phadke S, Byrnes EJ, Zhu P, Mueller O, Farrer RA, Henk DA, Lewit Y, Hsueh YP, Fisher MC, Idnurm A, Heitman J, May RC.

PLoS Genet. 2013;9(9):e1003771. doi: 10.1371/journal.pgen.1003771. Epub 2013 Sep 5.

Supplemental Content

Support Center